Monte Rosa Therapeutics, Inc. Profile Avatar - Palmy Investing

Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral mol…

Biotechnology
US, Boston [HQ]

Cash Flow Statements

Loading...
End of GLUE's Analysis
CIK: 1826457 CUSIP: 61225M102 ISIN: US61225M1027 LEI: - UEI: -
Secondary Listings
GLUE has no secondary listings inside our databases.